|
|
|
|
|
Levodopa |
|
Levodopa |
|
Levodopa Formula C9H11NO4 Molecular weight of 197.19 CAS No. 59-92-7 EINECS Registry No. 200-445-2 Melting point 295¡Æ C Than the optical rotation -11.7 o The (C = 5.3, 1N HCl) Hazard Symbols Xn (harmful) Risk Codes R22 (Harmful if swallowed) Safety instructions S24/25 (avoid contact with skin, eyes) Use: to antiparkinsonian drugs. Through the blood-brain barrier into the brain tissue into dopamine by dopa decarboxylase decarboxylation to play a role. For essential tremor paralysis and non-drug immunogenicity paralysis agitans syndrome, pair, mildly better, less severe or elderly.
|
|
Levodopa Formula C9H11NO4 Molecular weight of 197.19 CAS No. 59-92-7 EINECS Registry No. 200-445-2 Melting point 295¡Æ C Than the optical rotation -11.7 o The (C = 5.3, 1N HCl) Hazard Symbols Xn (harmful) Risk Codes R22 (Harmful if swallowed) Safety instructions S24/25 (avoid contact with skin, eyes) Use: to antiparkinsonian drugs. Through the blood-brain barrier into the brain tissue into dopamine by dopa decarboxylase decarboxylation to play a role. For essential tremor paralysis and non-drug immunogenicity paralysis agitans syndrome, pair, mildly better, less severe or elderly.
|
Industrial field |
pharmaceutical |
|
|
|
|
|
|
|
There are no existing companies to distribute selected chemical product |
|
|
|
|
|